These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23321661)

  • 41. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
    Takahashi K; Kawamura N; Ishiko O; Ogita S
    Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute urinary retention caused by a large impacted leiomyoma.
    Derbent A; Turhan NO
    Arch Gynecol Obstet; 2009 Dec; 280(6):1045-7. PubMed ID: 19333612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Role of medical treatment for symptomatic leiomyoma management in premenopausal women].
    Koskas M; Chabbert-Buffet N; Douvier S; Huchon C; Paganelli E; Derrien J
    J Gynecol Obstet Biol Reprod (Paris); 2011 Dec; 40(8):858-74. PubMed ID: 22071015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Corona stenting in a patient menorrhagia: use of a gonadotrophin releasing hormone agonist to facilitate anticoagulation.
    Khurana C; Taylor P; de Belder MA
    Int J Cardiol; 1998 Jan; 63(1):89-91. PubMed ID: 9482151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metachromasia of the endocervical epithelium in women treated with gonadotropin releasing hormone agonist.
    Morimura M; Ishiko O; Honda KI; Sumi T; Kawamura N; Wakasa K; Haba T; Ogita S
    Int J Mol Med; 2001 Sep; 8(3):319-21. PubMed ID: 11494062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphologic patterns of human endometrial epithelium in women with uterine myomata treated with leuprorelin acetate.
    Palmara V; Triolo O; Benedetto V; Lo Re C; Sturlese E; Retto G; Santoro G
    Gynecol Obstet Invest; 2010; 69(2):131-5. PubMed ID: 19996602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gonadotrophin-releasing hormone agonist and laparoscopic myomectomy.
    Dubuisson JB; Lecuru F; Foulot H; Mandelbrot L; Bouquet de la Jolinière J; Aubriot FX
    Clin Ther; 1992; 14 Suppl A():51-6. PubMed ID: 1535022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial.
    Coddington CC; Grow DR; Ahmed MS; Toner JP; Cook E; Diamond MP
    Fertil Steril; 2009 May; 91(5):1909-13. PubMed ID: 18439584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pulmonary densities following a hysterectomy, caused by benign metastatic leiomyoma].
    Scheer ML; Slebos DJ; Bogchelman DH; Timens W
    Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2027-31. PubMed ID: 18825892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary retention secondary to a uterine leiomyoma: is it nonpregnant incarceration of a retroverted uterus?
    Haylen BT
    Int Urogynecol J Pelvic Floor Dysfunct; 2007 Oct; 18(10):1247-8. PubMed ID: 17612777
    [No Abstract]   [Full Text] [Related]  

  • 51. Preoperative use of GnRH agonist for leiomyomas.
    Hutchins FL
    J Reprod Med; 1997 Apr; 42(4):253. PubMed ID: 9131502
    [No Abstract]   [Full Text] [Related]  

  • 52. Successes and failures of uterine leiomyoma drug discovery.
    Ali M; Chaudhry ZT; Al-Hendy A
    Expert Opin Drug Discov; 2018 Feb; 13(2):169-177. PubMed ID: 29254389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A rare case of uterine fibromyoma simulating acute intestinal obstruction and causing acute urinary retention].
    Tomusiak TL; Pytlyk VM; Shevchuk DI
    Klin Khir (1962); 1994; (12):57. PubMed ID: 9173131
    [No Abstract]   [Full Text] [Related]  

  • 54. Exacerbation of lupus nephritis in association with leuprorelin injection for uterine leiomyoma.
    Metcalfe W; Boulton-Jones JM
    Nephrol Dial Transplant; 1997 Aug; 12(8):1699-700. PubMed ID: 9269652
    [No Abstract]   [Full Text] [Related]  

  • 55. Female acute urinary retention caused by anterior deflection of the cervix which was augmented by an uterine myoma.
    Ding DC; Hwang KS
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):350-1. PubMed ID: 18936006
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term suppression of testosterone after treatment with a gonadotropin-releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor.
    Barnes RB; Ehrmann DA
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1746-8. PubMed ID: 9177374
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute urinary retention after gonadotropin-releasing hormone agonist treatment for leiomyomata uteri.
    Friedman AJ
    Fertil Steril; 1993 Mar; 59(3):677-8. PubMed ID: 8458477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary retention and uterine leiomyomas: a case series and systematic review of the literature.
    Wu CQ; Lefebvre G; Frecker H; Husslein H
    Int Urogynecol J; 2015 Sep; 26(9):1277-84. PubMed ID: 25752469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Acute urinary retention due to cervical myoma--a case report and a review of the literature].
    Bidziński M; Siergiej M; Radkiewicz J; Surynt E; Sikora S
    Ginekol Pol; 2015 Jan; 86(1):77-9. PubMed ID: 25775880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnetic resonance imaging of leiomyomata uteri: assessing therapy with the gonadotropin-releasing hormone agonist leuprolide.
    Lubich LM; Alderman MG; Ros PR
    Magn Reson Imaging; 1991; 9(3):331-4. PubMed ID: 1908932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.